Plasma activated protein C resistance

Rodeghiero F & Tosetto A: Activated protein C resistance and factor V Leiden mutation are independent risk factors for venous thromboembolism.. Ann Intern Med 1999; 130:643-650.

Tosetto A, Simioni M, Madeo D, et al: Intraindividual consistency of the activated protein C resistance phenotype. Br J Haematol 2004; 126(3):405-409.

Harvey D & Lowe GM: Factor V Leiden: association with venous thromboembolism in pregnancy and screening issues. Br J Biomed Sci 2004; 61(3):157-164.

Eckman MH, Erban JK, Singh SK, et al: Screening for the risk for bleeding or thrombosis. Ann Intern Med 2003; 138(3):W15-W24.

Kyrle PA & Eichinger S: Deep vein thrombosis. Lancet 2005; 365(9465):1163-1174.

Caprini JA, Glase CJ, Anderson CB, et al: Laboratory markers in the diagnosis of venous thromboembolism. Circulation 2004; 109(12 Suppl 1):I4-I8.

Nicolaes GA & Dahlback B: Congenital and acquired activated protein C resistance. Semin Vasc Med 2003; 3(1):33-46.